Search results for "Epidemiology"

showing 10 items of 4214 documents

The Epidemiology of Hip and Knee Primary and Revision Arthroplasties during the COVID-19 Pandemic

2021

Background: The purpose of this study was to provide a comprehensive assessment of the impact of the COVID-19 pandemic on the epidemiology of primary and revision arthroplasties of the hip and knee joint. Methods: This study compared the data on knee and hip arthroplasty procedures from 2 hospitals (primary and revision) conducted in two periods: the period of the COVID-19 pandemic in Poland (from 4 March 2020 to 15 October 2020) and the corresponding period prior to the pandemic (from 4 March 2019 to 15 October 2019). We compared the epidemiological data, demographic data, and hospital stay duration data from these two periods. Results: Our analysis demonstrated that the total number of hi…

musculoskeletal diseasesmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Leadership and Managementmedicine.medical_treatmentKnee replacementHealth InformaticsSARS-COV-2Knee JointArticle03 medical and health sciences0302 clinical medicineHealth Information ManagementEpidemiologyPandemicmedicineDuration data030222 orthopedicsknee revisionknee arthroplastiesbusiness.industryhip arthroplastiesHealth Policypandemiclock-downR030229 sport sciencesArthroplastySurgeryOrthopedic surgeryMedicineepidemiologyhip revisionbusinessCovid-19knee arthroplasties; hip arthroplasties; knee revision; hip revision; Covid-19; epidemiology; lock-down; pandemic; SARS-COV-2Healthcare
researchProduct

Is time to joint replacement a valid outcome measure in clinical trials of drugs for osteoarthritis?

2003

The rate of radiographic joint space narrowing is commonly used today as a structural outcome measure in clinical trials evaluating potential disease-modifying drugs in patients with hip osteoarthritis, but this results in a continuous variable. Among the methods proposed to circumvent this problem, it has been suggested that the incidence of total hip arthoplasty (THA) provides a hard outcome measure. It is a dichotomized variable, easy to measure and sensitive to change, with acceptable intrinsic validity. However, because this measure is limited by the variability of factors underlying the decision to perform surgery and the length of waiting lists, it has been suggested that time to ful…

musculoskeletal diseasesmedicine.medical_specialtyTime FactorsJoint replacementEndpoint Determinationmedicine.medical_treatmentArthroplasty Replacement HipInternational CooperationMeasure (physics)OsteoarthritisContinuous variableRheumatologyReference ValuesArthropathyOsteoarthritismedicineHumansClinical Trials as Topicbusiness.industryIncidence (epidemiology)Outcome measuresmedicine.diseaseClinical trialTreatment OutcomePhysical therapybusinessRheumatic diseases clinics of North America
researchProduct

AB1394 Compliance and arthralgias in clinical therapy (compact): Assessment of the incidence of arthralgia, therapy costs and compliance within the f…

2013

Background Aromatase inhibitors (AI) are well established as adjuvant endocrine treatment for postmenopausal women with hormone receptor-positive (HR+) early breast cancer (EBC). Drug-induced myalgia or arthralgia is among the most frequently reported adverse drug reactions to AIs. Objectives Little is known about the pathomechanism by which AIs cause muscle and joint injury. The literature on skeletal muscle complaints with AIs is confusing, in part because of a lack of clear definitions. Myalgia/arthralgia is defined as muscle/joint pain and is likely to affect patients’ quality of life and compliance with AI medication . We designed a prospective trial to collect real world data on the e…

musculoskeletal diseasesmyalgiamedicine.medical_specialtybusiness.industryIncidence (epidemiology)ImmunologyAnastrozolemedicine.diseaseGeneral Biochemistry Genetics and Molecular Biologybody regionsTherapy complianceBreast cancerRheumatologyQuality of lifeInternal medicineJoint painConcomitantmedicinePhysical therapyImmunology and Allergymedicine.symptombusinessmedicine.drugAnnals of the Rheumatic Diseases
researchProduct

COVID‐19 in older adults: What are the differences with younger patients?

2020

Aim The present study aimed both to gain knowledge on the distinctive clinical characteristics of older adults with coronavirus disease 2019 (COVID‐19), in comparison with those of younger patients, and to identify risk factors for mortality. Methods A retrospective observational study was carried out of patients consecutively admitted to Doctor Peset University Hospital, Valencia (Spain) for COVID‐19 from 11 March to 28 April 2020. Every case was diagnosed by reverse transcription polymerase chain reaction or by serology test to detect antibodies. Demographic details, clinical characteristics, laboratory findings on admission and complications of each case were collected from electronic me…

myalgiaAdultMalemedicine.medical_specialtyAdolescentFevercoronavirusComorbiditySerology03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicine030502 gerontologyCOVID‐19Risk FactorsInternal medicinemedicineHumansHospital Mortalityclinical characteristicsolder adultsOxygen saturation (medicine)AgedRetrospective StudiesAged 80 and overCreatininebusiness.industrySARS-CoV-2Medical recordAge FactorsCOVID-19Retrospective cohort studyOdds ratioOriginal ArticlesMiddle AgedmortalityConfidence intervalHospitalizationchemistryCoughSpainORIGINAL ARTICLE: Epidemiology Clinical Practice and HealthFemalemedicine.symptom0305 other medical sciencebusiness030217 neurology & neurosurgeryGeriatrics & Gerontology International
researchProduct

Fourth case of louse-borne relapsing fever in Young Migrant, Sicily, Italy, December 2015. Mini Review Article

2016

Abstract Objectives Currently louse-borne relapsing fever (LBRF) is primarily found in limited endemic foci in Ethiopia, Somalia and Sudan; no case of imported LBRF has been reported in Europe in the 9 years prior to 2015. The aim of our paper is to describe a new case of imported LBRF detected in Sicily, Italy, and to review all cases reported in migrants arrived in Europe in the last 10 years. Study design Mini review of all published cases of louse-borne relapsing fever in Europe in the last 10 years. Methods A computerized search without language restriction was conducted using PubMed combining the terms ‘(louse-borne relapsing fever or LBRF or recurrentis) and (refugee or Europe or mig…

myalgiaAdultMalemedicine.medical_specialtyPediatricsRefugeerelapsing feverSomalia030231 tropical medicineDiagnosis Differential03 medical and health sciences0302 clinical medicineEpidemiologyBorrelia recurrentis; Europe; Louse-borne relapsing fever; Refugees; Public Health Environmental and Occupational HealthmedicineHumans030212 general & internal medicineLouse-Borne Relapsing FeverSicilyTransients and MigrantsLouse-borne relapsing feverbiologyBorrelia recurrentibusiness.industryPublic healthBorreliaRelapsing FeverPublic Health Environmental and Occupational HealthGeneral MedicineLice Infestationsmedicine.diseasebiology.organism_classificationEuropeFamily medicineChillsmedicine.symptomHeadachesbusinessBorrelia recurrentis
researchProduct

A Single-Center (Sibiu, Romania), Retrospective Study (March–November 2020) of COVID-19 Clinical and Epidemiological Features in Children

2021

The aim of this study was to describe and analyze epidemiological and clinical features of children screened for COVID-19 at Sibiu Pediatric Clinical Hospital during the first 9 months (March–November) of coronavirus disease pandemic in Romania. A total of 203 pediatric patients with a confirmed diagnosis of COVID-19 were included in the study. The median age of the patients was 121 (IQR 18–181) months and 52.22% had mild clinical type with pneumonia, 35.47% were moderate cases, 3.94% severe cases, 0.99% critically ill cases and 7.39% were asymptomatic. The most common symptoms were fever (n = 130, 64.03%), nasal congestion (n = 138, 67.98%), cough (n = 128, 63.05%) followed by sore throat …

myalgiamedicine.medical_specialtyAbdominal painrhinorrheaclinical featuresbusiness.industrySARS-CoV-2coronavirusRCOVID-19General MedicineNasal congestionAsymptomaticArticlepediatricchildrenInternal medicinemedicineVomitingSore throatMedicineepidemiologyLeukocytosismedicine.symptombusinessJournal of Clinical Medicine
researchProduct

Associations of physical performance and physical activity with mental well-being in middle-aged women

2021

Abstract Background To investigate whether physical performance is independently of physical activity (PA) associated with positive and negative dimensions of mental well-being in middle-aged women. Methods Data were drawn from the Estrogenic Regulation of Muscle Apoptosis (ERMA) study in which women 47 to 55 years were randomly selected from the Finnish National Registry. They (n = 909) participated in measurements of physical performance (handgrip force, knee extension force, vertical jumping height, maximal walking speed, and six-minute walking distance). Both mental well-being (the Centre for Epidemiologic Studies Depression Scale, the International Positive and Negative Affect Schedule…

naisetaffektiivisuusPhysical performance0302 clinical medicinedepressive symptomsPositive affectivityBayesian multivariate linear regressionEpidemiology030212 general & internal medicineFinlandmiddle-age women030219 obstetrics & reproductive medicineHand StrengthDepressionDepressive symptomsMiddle AgedPhysical Functional Performancekeski-ikäisetMental HealthPositive affectivityMarital statuspositive affectivityaerobinen suorituskykyFemaleLife satisfactionPublic aspects of medicineRA1-1270Clinical psychologyResearch Articlemasennusmedicine.medical_specialtyNegative affectivityNegative affectivity03 medical and health sciencesAerobic capacitymedicineHumanslife satisfactionExerciseMiddle-age womensuorituskykybusiness.industryPublic Health Environmental and Occupational HealthLife satisfactionphysical performancenegative affectivityPreferred walking speedaerobic capacityCross-Sectional StudiestyytyväisyysBiostatisticsbusinessBMC Public Health
researchProduct

Global epidemiology of coronavirus disease 2019 and lessons for effective control of this and future pandemics

2021

Barely 1 year after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first reported in China, the virus has infected approximately 120 million people, caused around 3 million deaths, and adversely affected the global economy Despite stringent measures to flatten the epidemiologic curve of the pandemic, there have been spikes and waves of the infection in many countries, particularly in the American, European, and Asian continents This review critically evaluated the global epidemiology of the novel coronavirus disease 2019 (COVID-19) to provide advice on other possible ways of managing the disease as various COVID-19 vaccines are being rolled out To effectively control this …

new variant sars-cov-2pandemic diseasesmedicine.medical_specialtyEconomic growthcoronavirusesWildlifelcsh:MedicineDiseaseemerging zoonosesPublic domain03 medical and health sciences0302 clinical medicineEpidemiologyPandemicmedicine030212 general & internal medicineLicense030304 developmental biology0303 health scienceslcsh:R5-920General VeterinaryHealth Policypublic healthlcsh:RPublic Health Environmental and Occupational HealthWaiverVDP::Matematikk og Naturvitenskap: 400::Matematikk: 410sars-cov-2Infectious DiseasesGeographyOne Healthcovid-19lcsh:Medicine (General)International Journal of One Health
researchProduct

Niewydolność serca - problem medyczny, ekonomiczny i społeczny

2019

Pierwsze wzmianki o chorobie, którą dzisiaj określamy jako niewydolność serca, pochodzą z czasów antycznych. Epidemiologia objawowej niewydolności serca jest dobrze poznana, szczególnie w Europie. Na naszym kontynencie niewydolność serca występuje u około 2% dorosłej populacji. W artykule przedstawiono: defnicję, epidemiologię i rokowanie chorych z niewydolnością serca. Opracowanie charakteryzuje aktualne metody farmakoterapii i leczenia interwencyjnego. Ważnym elementem postępowania u chorych z niewydolnością serca jest rehabilitacja medyczna i przestrzeganie zasad proflaktyki chorób sercowo-naczyniowych zalecanych przez Europejskie Towarzystwo Kardiologiczne. Artykuł porusza również temat…

niewydolność sercaheart failureepidemiologyepidemiologialeczenie i prewencja niewydolności sercaheart failure treatment and preventionWiadomości Lekarskie
researchProduct

Etiological factors of chronic hepatitis in Italy: a 2014 national survey.

2017

Background The last Italian prevalence survey on chronic hepatitis (CH) conducted in 2001 showed that the hepatitis C virus (HCV) was the main agent associated with CH. Aim The aim of this study was to evaluate epidemiological changes in CH occurring after 13 years. Patients and methods Enrollment of 1392 CH consecutive patients referred to 16 Italian liver units in 2014 scattered all over the country (four in the North, four in the Center, four in the South, and four in the Islands) was performed. Results The mean age of the patients was 58.3 years, with a sex ratio (male/female) of 1.5. HCV infection (also with other etiologies) continues to be the most prevalent etiology (58.1%). However…

nonalcoholic fatty liver diseaseAdultMalemedicine.medical_specialtyPediatricsTime FactorsTime FactorAdolescentHepatitis C virusmedicine.disease_causemetabolic syndrome03 medical and health sciencesYoung Adult0302 clinical medicinechronic hepatitiRisk FactorsEpidemiologyNonalcoholic fatty liver diseasemedicinePrevalenceHumansAgedHepatitis ChronicHepatitisAged 80 and overHepatologybusiness.industryRisk FactorGastroenterologyEntecavirHepatitis CHealth SurveyHepatitis BHepatitis C ChronicMiddle Agedmedicine.diseaseHealth SurveysItaly030220 oncology & carcinogenesisEtiology030211 gastroenterology & hepatologyFemalehepatitis C virus infectionbusinessHumanmedicine.drugEuropean journal of gastroenterologyhepatology
researchProduct